MedPath

VIROGENICS, INC.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Safety, Tolerability and Pharmacokinetics of CMS121, a Drug Candidate for Alzheimer's Disease, in Healthy Subjects

Phase 1
Completed
Conditions
Alzheimer Disease
Interventions
Drug: Placebo
First Posted Date
2022-04-08
Last Posted Date
2023-02-16
Lead Sponsor
Virogenics, Inc.
Target Recruit Count
99
Registration Number
NCT05318040
Locations
🇺🇸

Celerion, Lincoln, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath